EAN 2021 | Developing precision medicine approaches in epilepsy

Eugen Trinka, MD, Paracelsus Medical University Salzburg, Salzburg, Austria, talks on evolving approaches to epilepsy treatment which utilize precision and personalized medicine to optimize individual outcomes. In several genetically defined epilepsy syndromes, effective treatments are now available that target the underlying molecular mechanisms. For example, in tuberous sclerosis, overactivity of the mTOR pathway via mutations in the TSC1 and TSC2 tumor suppressor genes can be targeted with mTOR inhibitors such as everolimus. Research aiming to apply this targeted approach in more epilepsies is under way. In multifactorial epilepsies, computational analysis and artificial intelligence is becoming more widely employed to improve diagnosis. This interview took place during the European Academy of Neurology 2021 congress.